1GA
TEVA icon

1st Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

1st Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,584
Closed -$456K – 539
2016
Q4 		$456K Sell
12,584
-32,097
-72% -$1.28M 0.06% 280
2016
Q3 		$2.06M Sell
44,681
-1,937
-4% -$101K 0.27% 47
2016
Q2 		$2.34M Buy
46,618
+33,150
+246% +$1.76M 0.32% 36
2016
Q1 		$721K Buy
13,468
+2,710
+25% +$159K 0.1% 171
2015
Q4 		$706K Buy
10,758
+5,129
+91% +$317K 0.11% 144
2015
Q3 		$318K Sell
5,629
-130
-2% -$8.43K 0.05% 299
2015
Q2 		$340 Sell
5,759
-177
-3% -$10.9K 0.05% 296
2015
Q1 		$370K Buy
+5,936
New +$345K 0.05% 277

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

1st Global Advisors's TEVA Position: Q1 2017 in Review

1st Global Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 12,584 shares — an estimated $456K sold.

1st Global Advisors first reported a position in TEVA in Q1 2015 and held it in 8 quarters. The position peaked at $2.34M in Q2 2016. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • 1st Global Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • 1st Global Advisors sold 12,584 Teva Pharmaceuticals shares in Q1 2017, an estimated $456K.
  • 1st Global Advisors first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 8 quarters.
  • 1st Global Advisors's Teva Pharmaceuticals position peaked at $2.34M in Q2 2016.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on 1st Global Advisors's 13F filing for Q1 2017, filed 9 May 2017.